stoxline Quote Chart Rank Option Currency Glossary
  
Zimmer Biomet Holdings, Inc. (ZBH)
107.86  1.61 (1.52%)    06-21 16:00
Open: 106.7
High: 108.04
Volume: 1,475,506
  
Pre. Close: 106.25
Low: 106
Market Cap: 22,190(M)
Technical analysis
2024-06-21 4:56:27 PM
Short term     
Mid term     
Targets 6-month :  135.2 1-year :  142.69
Resists First :  115.75 Second :  122.16
Pivot price 110.17
Supports First :  105.37 Second :  87.67
MAs MA(5) :  107 MA(20) :  111.53
MA(100) :  121.87 MA(250) :  121.02
MACD MACD :  -3.3 Signal :  -3.1
%K %D K(14,3) :  12.9 D(3) :  9.9
RSI RSI(14): 30.1
52-week High :  147.5 Low :  102
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ ZBH ] has closed above bottom band by 31.6%. Bollinger Bands are 55.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 108.11 - 108.76 108.76 - 109.39
Low: 104.46 - 105.22 105.22 - 105.96
Close: 106.67 - 107.81 107.81 - 108.91
Company Description

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Headline News

Sun, 23 Jun 2024
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Shares Sold by Douglas Lane & Associates LLC - MarketBeat

Sun, 23 Jun 2024
Mather Group LLC. Purchases New Position in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World

Sat, 22 Jun 2024
Nomura Holdings Inc. Invests $513000 in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World

Fri, 21 Jun 2024
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Fri, 21 Jun 2024
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

Fri, 21 Jun 2024
Cwm LLC Has $821000 Stock Holdings in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 206 (M)
Shares Float 205 (M)
Held by Insiders 0.1 (%)
Held by Institutions 92.1 (%)
Shares Short 5,650 (K)
Shares Short P.Month 4,250 (K)
Stock Financials
EPS 4.61
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 61.24
Profit Margin 12.9 %
Operating Margin 20.7 %
Return on Assets (ttm) 4.4 %
Return on Equity (ttm) 7.8 %
Qtrly Rev. Growth 3.2 %
Gross Profit (p.s.) 0
Sales Per Share 36.21
EBITDA (p.s.) 12
Qtrly Earnings Growth -24.3 %
Operating Cash Flow 1,500 (M)
Levered Free Cash Flow 1,070 (M)
Stock Valuations
PE Ratio 23.39
PEG Ratio 2
Price to Book value 1.76
Price to Sales 2.97
Price to Cash Flow 14.79
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android